跳到正文
openFDA 已分级药品召回执法报告·· 8 天前精选AI 评分75

FDA 执法报告 D-0856-2026:Sterling Pharmaceutical Services 因缺乏无菌保证召回 5% 高渗氯化钠滴眼液,分级 Class II

FDA drug enforcement D-0856-2026: Sterling Pharmaceutical Services LLC — Lack of Assurance of Sterility

AI 导读

FDA 在执法报告 D-0856-2026 中将 Sterling Pharmaceutical Services 自愿召回的 5% 高渗氯化钠滴眼液列为 Class II,原因为缺乏无菌保证。

推荐理由

该执法报告列出 Sterling Pharmaceutical Services 召回产品的分级、批次与分销范围,可用于核对无菌保证缺陷的产品层面信息。

正文 · AI 翻译

FDA 药品召回执法报告 — D-0856-2026

报告发布日期:2026-09-30。这是执法报告日期,不是召回启动日期。

范围:一条已分类的药品召回记录;event_id 可能归组多个产品。没有召回编号的未分类记录不在本数据流内。本记录不是新闻稿,也不是新的执法认定。

openFDA 数据集每周更新。报告状态不是实时召回状态,不得用于跟踪召回生命周期。以下其他日期保留其各自名称所表示的含义。

完整官方产品记录(包括 openFDA 统一标识符):

{

"address_1": "109 S 2nd St",

"address_2": "",

"center_classification_date": "20260921",

"city": "Dupo",

"classification": "Class II",

"code_info": "Lot #3192, Exp Date 01/312027; 3293, 3336 Exp Date 06/30/2027",

"country": "United States",

"distribution_pattern": "USA Nationwide",

"event_id": "99712",

"initial_firm_notification": "Letter",

"more_code_info": "",

"openfda": {

"application_number": [

"M018"

],

"brand_name": [

"SODIUM CHLORIDE HYPERTONICITY OPHTHALMIC SOLUTION, 5%"

],

"generic_name": [

"SODIUM CHLORIDE HYPERTONICITY OPHTHALMIC SOLUTION, 5%"

],

"is_original_packager": [

true

],

"manufacturer_name": [

"Reliable 1 Laboritories LLC"

],

"package_ndc": [

"69618-077-55"

],

"product_ndc": [

"69618-077"

],

"product_type": [

"HUMAN OTC DRUG"

],

"route": [

"OPHTHALMIC"

],

"rxcui": [

"730780"

],

"spl_id": [

"2bc84e6b-f871-1be7-e063-6294a90ac878"

],

"spl_set_id": [

"29175c17-223e-5e92-e063-6294a90a71d2"

],

"substance_name": [

"SODIUM CHLORIDE"

],

"unii": [

"451W47IQ8X"

]

},

"postal_code": "62239-1351",

"product_description": "Reliable -1 Laboratories, Sodium Chloride Hypertonicity Ophthalmic Solution, 5%, Sterile, 0.5 FL OZ (15 mL) bottles, Distributed by: Reliable-1 Laboratories LLC, Valley Stream, NY, 11580, NDC 69618-077-55.",

"product_quantity": "11083 bottles",

"product_type": "Drugs",

"reason_for_recall": "Lack of Assurance of Sterility",

"recall_initiation_date": "20260820",

"recall_number": "D-0856-2026",

"recalling_firm": "Sterling Pharmaceutical Services LLC",

"report_date": "20260930",

"state": "IL",

"status": "Ongoing",

"voluntary_mandated": "Voluntary: Firm initiated"

}

来源:openFDA 已分级药品召回执法报告 · api.fda.gov